1.0Laos Alliance Pharmaceutical Grouphttps://alliancepharmagroup.com/lorich600338<blockquote class="wp-embedded-content" data-secret="yxwsjTyWk0"><a href="https://alliancepharmagroup.com/lo/ສິນຄ້າ/alivinekla/">ALIVINEKLA</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://alliancepharmagroup.com/lo/ສິນຄ້າ/alivinekla/embed/#?secret=yxwsjTyWk0" width="600" height="338" title="“ALIVINEKLA” — Laos Alliance Pharmaceutical Group" data-secret="yxwsjTyWk0" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script> /*! This file is auto-generated */ !function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document); //# sourceURL=https://alliancepharmagroup.com/wp-includes/js/wp-embed.min.js </script>https://alliancepharmagroup.com/wp-content/uploads/2024/12/Alivinekla.png12801280COMPOSITION Venetoclax....................................100mg INDICATION • This product is indicated for the treatment of adult patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). • In combination with azacitidine, or decitabine, or low dose cytarabine for the treatment of newly diagnosed acute myeloid leukemia (AML) in adults 75 years or older, or who have comorbidities that preclude use of intensive induction chemotherapy. PACKAGING: 120 tablets/bottle. Reg No: 11 L 127/24 Download ALIVINEKLA Drug Registration Certificate ... Read More